WCO, IOF and ESCEO have worked in partnership for several years to develop a unique European springtime meeting programme for healthcare professionals, researchers and young scientists. With over 4,500 participants, this has become the largest educational event and most vibrant clinical research forum for osteoporosis, osteoarthritis and musculoskeletal diseases in Europe.
WCO, IOF and ESCEO have worked in partnership for several years to develop a unique European springtime meeting programme for healthcare professionals, researchers and young scientists. With over 4,500 participants, this has become the largest educational event and most vibrant clinical research forum for osteoporosis, osteoarthritis and musculoskeletal diseases in Europe.
highlights
Main topics of the 15th WCO-IOF-ESCEO Congress
Calcium plus vitamin D supplementation and cardiovascular safety
Vitamin D levels, calcium nutrition and risk of fracture
Nutritional management of osteoporotic patients
Blocking bone breakdown and stimulating new bone
Bloccare la distruzione dell'osso stimolando la neoformazione
How to control osteoporosis bone pain
Sclerostin inhibition for severe osteoporosis
Hyaluronic acid salts in the management of osteoarthritis in Europe
Reducing fracture risk while increasing bone mass: what medications are available?
Preventing secondary osteoporosis: anabolic vs anti-resorptive therapy
Is it time to resurrect menopausal hormone therapy in osteoporosis?
Is it possible to phenotype patients in Osteoarthritis?
abstracts
Critical evaluation of promising markers for sarcopenia
Phase 2 trial of myostatin antibody in weak older fallers
Repeated loading influences cortical bone geometry and strength
Osteoporosis therapy in high risk residents living in l.t. care homes
Fracture risk prediction and its interaction with FRAX
